Related Experiment Video
Updated: Jun 15, 2026
07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications
1Department of Medical Education and Research, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
Journal of the Chinese Medical Association : JCMA
|March 17, 2010
Summary
The BRAF(V600E) mutation is common in papillary thyroid cancer (PTC) and linked to aggressive disease. Testing for this mutation aids PTC diagnosis, prognosis, and may guide targeted therapy development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Papillary thyroid cancer (PTC) is the most common endocrine malignancy.
- Genetic alterations, particularly in the MAPK pathway (e.g., BRAF mutations), are frequent in PTC.
- The BRAF(V600E) mutation is found in about 50% of PTC cases and associated with aggressive forms.
Purpose of the Study:
- To review the pathogenesis of PTC.
- To discuss the clinical implications of the BRAF(V600E) mutation in PTC diagnosis and prognosis.
- To explore potential BRAF-targeted therapeutic strategies for thyroid cancers.
Main Methods:
- Review of existing literature on PTC pathogenesis and BRAF(V600E) mutation.
- Analysis of clinical studies associating BRAF(V600E) with clinicopathologic characteristics and recurrence.
- Examination of preclinical and clinical trial data for BRAF-targeted therapies.
Main Results:
- BRAF(V600E) is a key driver in PTC development and progression.
- BRAF(V600E) is associated with aggressive PTC features and higher recurrence rates, though controversial.
- BRAF(V600E) testing improves diagnostic accuracy in indeterminate cytology and aids prognostication in low-risk PTC.
Conclusions:
- BRAF(V600E) mutation is a significant factor in PTC pathogenesis and clinical behavior.
- BRAF(V600E) testing offers valuable diagnostic and prognostic information for PTC patients.
- Targeted therapies for BRAF(V600E)-mutated thyroid cancer show promise but require further investigation.
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...